Figure 4
![Figure 4. Inhibition of tumor relapse by adoptive transfer of allogeneic anti–third-party Tcm. Lethally irradiated (8Gy TBI) BALB/c (H-2d) mice received an intravenous transplant of 3 × 106 allogeneic TDBM cells (B6 nude [H-2b]) in the presence or absence of 5 × 103A20-luc lymphoma cells (day 0). Mice were then (day +1) intravenously injected with 5 × 106 B6-derived anti–third-party Tcm (A20+ Allo Tcm; n = 7) or left untreated (A20 only; n = 8). (A) Tumor growth was monitored by BLI from day 13 at weekly intervals. (B) Survival rates of the animals in the different treatment groups are shown.](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/121/15/10.1182_blood-2012-06-432443/4/3033f4.jpeg?Expires=1724254396&Signature=wcTbJ1BgbhUsEzJq1QZpjj5YC7Je6T462y1FFBKG9e19iMXPVhjmrFsnTt5ezzua~PpbCa3y1TP17mM-geN6atO-tgwk17juJsk8miYTUKoY6kJiCkh-Us9kXH59DBsp5UMY0lwcAMJiG9z6zAO9knf7SYp9kkmvTHNTt34S0fQxXotlSS-DJixre4u2mQ32YKlKG~ysobj1lkSoQRhtgndAg0xHj82Prd4TVPTKqcxUdyEB~8kTBa0TRMiBvB4xgODKLDD0-L8reZTTvTVMb9mCa3pGZvaTb-OK9AuZAT6Qbp490m8POpg6O~2RFW9v1E4vaJMqZKB1pTJf5BGDiw__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Inhibition of tumor relapse by adoptive transfer of allogeneic anti–third-party Tcm. Lethally irradiated (8Gy TBI) BALB/c (H-2d) mice received an intravenous transplant of 3 × 106 allogeneic TDBM cells (B6 nude [H-2b]) in the presence or absence of 5 × 103A20-luc lymphoma cells (day 0). Mice were then (day +1) intravenously injected with 5 × 106 B6-derived anti–third-party Tcm (A20+ Allo Tcm; n = 7) or left untreated (A20 only; n = 8). (A) Tumor growth was monitored by BLI from day 13 at weekly intervals. (B) Survival rates of the animals in the different treatment groups are shown.
